(Q51572977)

7 April 2018

title

Postprandial hemorrheology and apolipoprotein B metabolism in patients with familial hypertriglyceridemia. (English)

1 reference

7 April 2018

author name string

Otto C

1

1 reference

7 April 2018

Pschierer V

2

1 reference

7 April 2018

Soennichsen AC

3

1 reference

7 April 2018

Schwandt P

4

1 reference

7 April 2018

Richter WO

5

1 reference

7 April 2018

publication date

1 November 1997

1 reference

7 April 2018

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Metabolism

1 reference

7 April 2018

volume

46

1 reference

7 April 2018

issue

11

1 reference

7 April 2018

page(s)

1299-1304

1 reference

7 April 2018

Fibrinogen as a risk factor for stroke and myocardial infarction

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

Association between serum fibrinogen concentrations and HDL and LDL subfraction phenotypes in healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

Atherogenesis: a postprandial phenomenon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

Postprandial lipoproteins and progression of coronary atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

Investigations into the haemorheological significance of postprandial and fasting hypertriglyceridaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

Treatment of primary chylomicronemia due to familial hypertriglyceridemia by omega-3 fatty acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

Bezafibrate lowers plasma lipids, fibrinogen and platelet aggregability in hypertriglyceridaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

Effect of short-term treatment with bezafibrate on plasma fibrinogen, fibrinopeptide A, platelet activation and blood filterability in atherosclerotic hyperfibrinogenemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

Effects of n-3 fatty acids and fenofibrate on lipid and hemorrheological parameters in familial dysbetalipoproteinemia and familial hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

Separation of apolipoprotein B subfractions by high performance gel permeation chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

RELATIONSHIP BETWEEN PLASMA TRIGLYCERIDES AND REMOVAL OF CHYLOMICRONS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

Metabolism of triglyceride-rich lipoproteins during alimentary lipemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

Effect of gemfibrozil on lipids, apoproteins, and postheparin lipolytic activities in normolipidemic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

Effect of gemfibrozil on adipose tissue and muscle lipoprotein lipase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

Effect of gemfibrozil on the concentration and composition of very low density and low density lipoprotein subfractions in hypertriglyceridemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

Apolipoprotein A and B (Sf 100-400) metabolism during bezafibrate therapy in hypertriglyceridemic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

Effect of gemfibrozil on the concentration and composition of serum lipoproteins. A controlled study with special reference to initial triglyceride levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

Effect of gemfibrozil on the regulation of HDL subfractions in hypertriglyceridaemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

Highly significant negative correlations between erythrocyte aggregation value and serum concentration of high density lipoprotein cholesterol in a sample from a normal population and in patients with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

A novel form of factor VII in plasma from men at risk for cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

Plasma fibrinogen in relation to serum insulin, smoking habits and adipose tissue fatty acids in healthy men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

Lack of association between haemostatic variables and the presence or the extent of coronary atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

ECAT angina pectoris study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

Treatment of severe diabetic hypertriglyceridaemia by plasma exchange

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

Blood viscosity--a comparative study on three rotational instruments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990234-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0026-0495(97)90234-1

1 reference

7 April 2018

1 reference

7 April 2018